Patient on $50,000-a-Week Cancer Drug Fears Leaving Behind Huge Medical Debt
After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the